FDA: Marketing Materials Encouraged Neurovascular Catheter Misuse
Executive Summary
Some manufacturers may be suggesting their guide catheters can be used to remove thrombus – an off-label use that could cause hemorrhage and other adverse events, FDA says.
You may also be interested in...
Stryker Devices Get First-Line US FDA Go-Ahead For Stroke
It’s a first-in-class indication for clot-retrieval devices that the firm gained in a 2011 acquisition.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.